Security Snapshot

Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) Institutional Ownership

CUSIP: 00974H104

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

0

Shares (Excl. Options)

0

Price

$1.29

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, $0.00001 par value per share
Symbol
AKYA
Shares outstanding
54,965,124
Price per share
$1.29
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-39,472
Value change
-$107,363
Number of holders
0
Price from insider filings
$1.29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share is tracked under CUSIP 00974H104.
  • 0 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 0 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $0 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 0 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 00974H104?
CUSIP 00974H104 identifies AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Quanterix Corp 56% -0.54% $38,811,973 +$3,615,179 30,560,609 +10% Quanterix Corporation 28 Apr 2025

Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$107,363 $1.29 0
2025 Q3 0 $0 -$16,297,621 $1.29 0
2025 Q2 12,538,172 $16,299,458 +$393,906 $1.30 57
2025 Q1 12,180,731 $16,933,516 -$396,175 $1.39 64
2024 Q4 12,134,199 $27,787,012 -$94,780 $2.29 60
2024 Q3 12,090,894 $32,886,405 -$636,504 $2.72 59
2024 Q2 12,385,236 $28,979,719 -$9,287,172 $2.34 58
2024 Q1 14,854,113 $69,665,707 +$272,730 $4.69 66
2023 Q4 14,746,467 $72,097,557 -$6,143,228 $4.88 62
2023 Q3 16,048,557 $74,626,912 -$4,377,853 $4.65 60
2023 Q2 16,061,952 $118,696,041 +$17,919,115 $7.39 72
2023 Q1 13,357,367 $109,090,839 -$6,745,365 $8.18 63
2022 Q4 14,068,910 $134,634,613 -$3,380,379 $9.57 71
2022 Q3 14,383,053 $169,004,351 +$16,199,753 $11.75 55
2022 Q2 12,982,721 $166,825,000 +$9,078,280 $12.85 52
2022 Q1 12,312,165 $135,320,000 -$258,605 $10.99 45
2021 Q4 12,136,619 $189,431,000 +$26,498,236 $15.31 44
2021 Q3 9,884,433 $137,984,289 -$15,853,081 $13.96 46
2021 Q2 10,064,753 $194,653,000 +$194,653,002 $19.34 60